CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KINIKSA PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$3,595,295
+16.6%
206,983
-5.5%
0.00%0.0%
Q2 2023$3,084,745
+31.6%
219,087
+0.6%
0.00%0.0%
Q1 2023$2,344,464
-23.9%
217,887
+6.0%
0.00%0.0%
Q4 2022$3,079,244
+17.3%
205,557
+0.5%
0.00%0.0%
Q3 2022$2,626,000
+224.2%
204,500
+144.9%
0.00%
Q2 2022$810,000
+5.6%
83,503
+8.3%
0.00%
Q1 2022$767,000
-14.8%
77,082
+0.8%
0.00%
Q4 2021$900,000
+6.5%
76,456
+3.1%
0.00%
Q3 2021$845,000
-13.8%
74,170
+5.5%
0.00%
Q2 2021$980,000
-19.1%
70,296
+7.4%
0.00%
Q1 2021$1,212,000
+4.2%
65,446
-0.6%
0.00%
Q4 2020$1,163,000
+15.1%
65,815
-0.2%
0.00%
Q3 2020$1,010,000
-15.8%
65,921
+40.1%
0.00%
-100.0%
Q2 2020$1,199,000
+118.0%
47,047
+32.5%
0.00%
Q1 2020$550,000
+63.2%
35,496
+16.6%
0.00%
Q4 2019$337,000
+8.7%
30,440
-16.4%
0.00%
Q3 2019$310,000
-36.5%
36,404
+1.1%
0.00%
Q2 2019$488,000
+12.4%
36,013
+50.1%
0.00%
Q1 2019$434,000
+3.6%
23,992
+61.0%
0.00%
Q4 2018$419,000
+10.3%
14,9000.0%0.00%
Q3 2018$380,00014,9000.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders